Primary melanomas showed two variations of CD9 staining: (a) an absolute loss of reactivity in the total of thin melanomas (24/24) (Figure 2g–i); (b) a reactivity limited to <50% of the total intermediate and thick melanomas, occurring in 44 of the 96 lesions (Table 4). The gene discussed is CD9; the disease is melanoma.